Boston Scientific Corp. has issued a worldwide voluntary recall for an older version of one of its most commercially promising devices, the Lotus transcatheter aortic heart valve replacement system, following the deaths of three patients.
The Aug. 1 recall affects about 250 Lotus valve systems that were manufactured before March 2016 but have not yet been implanted in patients. About 15 of the devices are in the U.S.
